These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 23971242)

  • 1. Colostrum in menopause effects on vaginal cytology/symptoms.
    Tucci S; Mancini R; De Vitis C; Noto A; Marra E; Lukic A; Giovagnoli MR; Moscarini M
    Clin Exp Obstet Gynecol; 2013; 40(2):219-21. PubMed ID: 23971242
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monurelle Biogel
    Nappi RE; Cagnacci A; Becorpi AM; Nappi C; Paoletti AM; Busacca M; Martella S; Bellafronte M; Tredici Z; Di Carlo C; Corda V; Vignali M; Bagolan M; Sardina M
    Climacteric; 2017 Oct; 20(5):467-475. PubMed ID: 28657769
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treating Menopausal Symptoms.
    Am Fam Physician; 2016 Dec; 94(11):Online. PubMed ID: 27929272
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparative study: Replens versus local estrogen in menopausal women.
    Nachtigall LE
    Fertil Steril; 1994 Jan; 61(1):178-80. PubMed ID: 8293835
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Randomized, Multicenter, Double-Blind, Study to Evaluate the Safety and Efficacy of Estradiol Vaginal Cream 0.003% in Postmenopausal Women with Vaginal Dryness as the Most Bothersome Symptom.
    Archer DF; Kimble TD; Lin FDY; Battucci S; Sniukiene V; Liu JH
    J Womens Health (Larchmt); 2018 Mar; 27(3):231-237. PubMed ID: 29193980
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pelvic floor muscles training to reduce symptoms and signs of vulvovaginal atrophy: a case study.
    Mercier J; Morin M; Lemieux MC; Reichetzer B; Khalifé S; Dumoulin C
    Menopause; 2016 Jul; 23(7):816-20. PubMed ID: 27219835
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An overview of chronic vaginal atrophy and options for symptom management.
    Woods NF
    Nurs Womens Health; 2012 Dec; 16(6):482-93; quiz 494. PubMed ID: 23253575
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Topical treatment of vaginal dryness with a non-hormonal cream in women undergoing breast cancer treatment - An open prospective multicenter study.
    Chatsiproios D; Schmidts-Winkler IM; König L; Masur C; Abels C
    PLoS One; 2019; 14(1):e0210967. PubMed ID: 30677065
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical trial shows lasting function of a new moisturizing cream against vaginal dryness.
    Henneicke-von Zepelin HH; Williams R; Havemeister W; Wigger-Alberti W; Nolte KU
    Wien Med Wochenschr; 2017 May; 167(7-8):189-195. PubMed ID: 28091974
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and tolerability of a plant-based, multi-component cream (Ginetrox®) in vulvovaginal disorders of the genitourinary syndrome during menopause.
    Marrai R; Lissi G; Togni S; Maramaldi G; Barbara M; Giacomelli L
    Minerva Ginecol; 2017 Jun; 69(3):245-249. PubMed ID: 28420227
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Technological evolution in the radiofrequency treatment of vaginal laxity and menopausal vulvo-vaginal atrophy and other genitourinary symptoms: first experiences with a novel dynamic quadripolar device.
    Vicariotto F; Raichi M
    Minerva Ginecol; 2016 Jun; 68(3):225-36. PubMed ID: 27206062
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-hormonal topical treatment of vulvovaginal atrophy: an up-to-date overview.
    Sinha A; Ewies AA
    Climacteric; 2013 Jun; 16(3):305-12. PubMed ID: 23215675
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of oestriol gel on dyspareunia in postmenopausal women in 2 weeks of treatment: a pilot study.
    Cuerva MJ; González SP; Lazaro-Carrasco De La Fuente J; Lopez FJ; Nieto C
    J Obstet Gynaecol; 2022 Oct; 42(7):3397-3399. PubMed ID: 35658728
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is vaginal hyaluronic acid as effective as vaginal estriol for vaginal dryness relief?
    Stute P
    Arch Gynecol Obstet; 2013 Dec; 288(6):1199-201. PubMed ID: 24178484
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dynamic quadripolar radiofrequency treatment of vaginal laxity/menopausal vulvo-vaginal atrophy: 12-month efficacy and safety.
    Vicariotto F; DE Seta F; Faoro V; Raichi M
    Minerva Ginecol; 2017 Aug; 69(4):342-349. PubMed ID: 28608667
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravaginal Testosterone Improves Sexual Satisfaction and Vaginal Symptoms Associated With Aromatase Inhibitors.
    Davis SR; Robinson PJ; Jane F; White S; White M; Bell RJ
    J Clin Endocrinol Metab; 2018 Nov; 103(11):4146-4154. PubMed ID: 30239842
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of Glycine max (L.) Merr. soy isoflavone vaginal gel on epithelium morphology and estrogen receptor expression in postmenopausal women: a 12-week, randomized, double-blind, placebo-controlled trial.
    Lima SM; Bernardo BF; Yamada SS; Reis BF; da Silva GM; Galvão MA
    Maturitas; 2014 Jul; 78(3):205-11. PubMed ID: 24856055
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Replens versus dienoestrol cream in the symptomatic treatment of vaginal atrophy in postmenopausal women.
    Bygdeman M; Swahn ML
    Maturitas; 1996 Apr; 23(3):259-63. PubMed ID: 8794418
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized, multicenter, double-blind study to evaluate the safety and efficacy of estradiol vaginal cream 0.003% in postmenopausal women with dyspareunia as the most bothersome symptom.
    Kroll R; Archer DF; Lin Y; Sniukiene V; Liu JH
    Menopause; 2018 Feb; 25(2):133-138. PubMed ID: 28926514
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effective treatment of vaginal atrophy with isoflavone vaginal gel.
    Lima SM; Yamada SS; Reis BF; Postigo S; Galvão da Silva MA; Aoki T
    Maturitas; 2013 Mar; 74(3):252-8. PubMed ID: 23312487
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.